当前位置: 首页 > 期刊 > 《中国社区医师》 > 20185
编号:13600443
叶酸干预对急性冠脉综合征患者PCI术后Hcy、FIB浓度及预后的影响(2)
http://www.100md.com 2018年2月5日 《中国社区医师》 20185
     参考文献

    [1]刘兆平,霍勇.经皮冠状动脉介入治疗规范化管理[J].中国医学前沿杂志(电子版),2015,7(1):7-8.

    [2] Wald DS, Law M,Moms JK, Homocystdneand cardiovasculardisease:ewdence on cau-sality from a meta-analysis[J].BMJ,2002,325(7374):1202-1206.

    [3]

    Sun Q,Jia X,Gao J.Association of serum ho-mocysteine levels with the Severity and cal-cification of coronary atherose leroticplaques detected by coronary CT angiogra-phy[J].lntemational Angiology, 2014, 33(4):316-323.

    [4] Empana JP.Canoui-Poitrine F,Luc Get,al.Contribution of novel biomarkers to incidentstahle angina and acute coronary syndrome:the PRIME Study [J].Eur Heart J,2008,29(16):1966-1974.

    [5]

    Danesh J.Collins R,Appleby P,et al.Associa-tionof fibrinogen,c-reactive protein,albumin,0r leukocyte count with coronary heart dis-ease:meta-analyses of prospective studies[J].JAMA,1998,279(18):1477-1482.

    [6]李俊,李彬,齊娟飞,等.联用叶酸、维生素B6和维生素B12降低同型半胱氨酸水平影响心血管疾病风险的荟萃分析[J].中华心血管病杂志,2015,(43):554-561.

    [7] Schnyder G,Roffi M,Fiammer Y,et al.Effectof homocysteine-iowering therapy with foiicacid,vitamin B12,and vitamin B6 0n ciinicaioutcome after percutaneous coronary inter-vention:the Swiss Heart study:a randomizedcontroiied triai[J]. JAMA, 2002, 288(8):973-979., http://www.100md.com(齐囡囡 刘松)
上一页1 2